Mirikizumab 100mg/1ml solution for injection pre-filled disposable devices
NHS hospitals in England used £19,471,510 of indicative cost of Mirikizumab 100mg/1ml solution for injection pre-filled disposable devices in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 201.8% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Mirikizumab 100mg/1ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Mirikizumab 100mg/1ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Salford Royal Nhs Foundation Trust | £1,349,103 |
| Oxford University Hospitals Nhs Ft | £1,239,077 |
| Guy's & St Thomas' Nhs Foundation Trust | £894,604 |
| North Bristol Nhs Trust | £762,984 |
| Leeds Teaching Hpls Nhs Trust | £756,814 |
| Hull And East Yorkshire Hpls Nhs Trust | £742,418 |
| Barts Health Nhs Trust | £736,248 |
| Western Sussex Hospitals Nhs Found Trust | £710,541 |
| Gloucestershire Hpls Nhs Foundation Trst | £684,834 |
| St George's Univ Hosps Foundation Nhst | £670,439 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.